| How does mindfulness meditation work? Proposing mechanisms of action from a conceptual and neural perspective BK Hölzel, SW Lazar, T Gard, Z Schuman-Olivier, DR Vago, U Ott Perspectives on psychological science 6 (6), 537-559, 2011 | 3943 | 2011 |
| Mindfulness and behavior change Z Schuman-Olivier, M Trombka, DA Lovas, JA Brewer, DR Vago, ... Harvard review of psychiatry 28 (6), 371-394, 2020 | 236 | 2020 |
| Mindfulness and cardiovascular disease risk: state of the evidence, plausible mechanisms, and theoretical framework EB Loucks, Z Schuman-Olivier, WB Britton, DM Fresco, G Desbordes, ... Current cardiology reports 17, 1-11, 2015 | 180 | 2015 |
| Emerging adult age status predicts poor buprenorphine treatment retention Z Schuman-Olivier, RD Weiss, BB Hoeppner, J Borodovsky, MJ Albanese Journal of substance abuse treatment 47 (3), 202-212, 2014 | 130 | 2014 |
| Self-treatment: illicit buprenorphine use by opioid-dependent treatment seekers Z Schuman-Olivier, M Albanese, SE Nelson, L Roland, F Puopolo, ... Journal of substance abuse treatment 39 (1), 41-50, 2010 | 116 | 2010 |
| Interoception in psychiatric disorders: a review of randomized, controlled trials with interoception-based interventions NM Khoury, J Lutz, Z Schuman-Olivier Harvard review of psychiatry 26 (5), 250-263, 2018 | 114 | 2018 |
| A Controlled Study of a Spirituality–Focused Intervention for Increasing Motivation for HIV Prevention Among Drug Users A Margolin, M Beitel, Z Schuman-Olivier, SK Avants AIDS Education & Prevention 18 (4), 311-322, 2006 | 105 | 2006 |
| A preliminary study of spiritual self‐schema (3‐S+) therapy for reducing impulsivity in HIV‐positive drug users A Margolin, Z Schuman‐Olivier, M Beitel, RM Arnold, CE Fulwiler, ... Journal of clinical psychology 63 (10), 979-999, 2007 | 103 | 2007 |
| Technological interventions for medication adherence in adult mental health and substance use disorders: a systematic review JM Steinkamp, N Goldblatt, JT Borodovsky, A LaVertu, IM Kronish, ... JMIR mental health 6 (3), e12493, 2019 | 97 | 2019 |
| Mindfulness-based cognitive therapy for bipolar disorder: A systematic review DA Lovas, Z Schuman-Olivier Journal of affective disorders 240, 247-261, 2018 | 97 | 2018 |
| An examination of mindfulness-based programs in US medical schools N Barnes, P Hattan, DS Black, Z Schuman-Olivier Mindfulness 8 (2), 489-494, 2017 | 94 | 2017 |
| The use of palliative sedation for existential distress: a psychiatric perspective Z Schuman-Olivier, DH Brendel, M Forstein, BH Price Harvard review of psychiatry 16 (6), 339-351, 2008 | 93 | 2008 |
| Benzodiazepine use during buprenorphine treatment for opioid dependence: clinical and safety outcomes Z Schuman-Olivier, BB Hoeppner, RD Weiss, J Borodovsky, HJ Shaffer, ... Drug and alcohol dependence 132 (3), 580-586, 2013 | 74 | 2013 |
| Mindfulness training enhances self-regulation and facilitates health behavior change for primary care patients: a randomized controlled trial R Gawande, MN To, E Pine, T Griswold, TB Creedon, A Brunel, A Lozada, ... Journal of general internal medicine 34, 293-302, 2019 | 66 | 2019 |
| Reflections by inner‐city drug users on a Buddhist‐based spirituality‐focused therapy: A qualitative study M Beitel, M Genova, Z Schuman‐Olivier, R Arnold, SK Avants, A Margolin American Journal of Orthopsychiatry 77 (1), 1-9, 2007 | 65 | 2007 |
| Mindfulness in migraine: A narrative review RE Wells, EK Seng, RR Edwards, DE Victorson, CR Pierce, L Rosenberg, ... Expert review of neurotherapeutics 20 (3), 207-225, 2020 | 55 | 2020 |
| Group-based treatment of opioid use disorder with buprenorphine: A systematic review R Sokol, AE LaVertu, D Morrill, C Albanese, Z Schuman-Olivier Journal of substance abuse treatment 84, 78-87, 2018 | 55 | 2018 |
| Is residential treatment effective for opioid use disorders? A longitudinal comparison of treatment outcomes among opioid dependent, opioid misusing, and non-opioid using … Z Schuman-Olivier, MC Greene, BG Bergman, JF Kelly Drug and Alcohol Dependence 144, 178-185, 2014 | 51 | 2014 |
| MySafeRx: a mobile technology platform integrating motivational coaching, adherence monitoring, and electronic pill dispensing for enhancing buprenorphine … Z Schuman-Olivier, JT Borodovsky, J Steinkamp, Q Munir, K Butler, ... Addiction science & clinical practice 13, 1-14, 2018 | 44 | 2018 |
| Clinician beliefs and attitudes about buprenorphine/naloxone diversion Z Schuman‐Olivier, H Connery, ML Griffin, SA Wyatt, AA Wartenberg, ... The American Journal on Addictions 22 (6), 574-580, 2013 | 42 | 2013 |
